DOI QR코드

DOI QR Code

Nonstructural NS5A Protein Regulates LIM and SH3 Domain Protein 1 to Promote Hepatitis C Virus Propagation

  • Choi, Jae-Woong (Laboratory of RNA Viral Diseases, Korea Zoonosis Research Institute, Jeonbuk National University) ;
  • Kim, Jong-Wook (Ilsong Institute of Life Science, Hallym University) ;
  • Nguyen, Lap P. (Laboratory of RNA Viral Diseases, Korea Zoonosis Research Institute, Jeonbuk National University) ;
  • Nguyen, Huu C. (Laboratory of RNA Viral Diseases, Korea Zoonosis Research Institute, Jeonbuk National University) ;
  • Park, Eun-Mee (Center for Immunology and Pathology, National Institute of Health, Korea Center for Disease Control & Prevention) ;
  • Choi, Dong Hwa (Biocenter, Gyeonggido Business & Science Accelerator) ;
  • Han, Kang Min (Department of Pathology, Dongguk University Ilsan Hospital) ;
  • Kang, Sang Min (Laboratory for Infectious Disease Prevention, Korea Zoonosis Research Institute, Jeonbuk National University) ;
  • Tark, Dongseob (Laboratory for Infectious Disease Prevention, Korea Zoonosis Research Institute, Jeonbuk National University) ;
  • Lim, Yun-Sook (Laboratory of RNA Viral Diseases, Korea Zoonosis Research Institute, Jeonbuk National University) ;
  • Hwang, Soon B. (Laboratory of RNA Viral Diseases, Korea Zoonosis Research Institute, Jeonbuk National University)
  • Received : 2020.01.14
  • Accepted : 2020.03.20
  • Published : 2020.05.31

Abstract

Hepatitis C virus (HCV) propagation is highly dependent on cellular proteins. To identify the host factors involved in HCV propagation, we previously performed protein microarray assays and identified the LIM and SH3 domain protein 1 (LASP-1) as an HCV NS5A-interacting partner. LASP-1 plays an important role in the regulation of cell proliferation, migration, and protein-protein interactions. Alteration of LASP-1 expression has been implicated in hepatocellular carcinoma. However, the functional involvement of LASP-1 in HCV propagation and HCV-induced pathogenesis has not been elucidated. Here, we first verified the protein interaction of NS5A and LASP-1 by both in vitro pulldown and coimmunoprecipitation assays. We further showed that NS5A and LASP-1 were colocalized in the cytoplasm of HCV infected cells. NS5A interacted with LASP-1 through the proline motif in domain I of NS5A and the tryptophan residue in the SH3 domain of LASP-1. Knockdown of LASP1 increased HCV replication in both HCV-infected cells and HCV subgenomic replicon cells. LASP-1 negatively regulated viral propagation and thereby overexpression of LASP-1 decreased HCV replication. Moreover, HCV propagation was decreased by wild-type LASP-1 but not by an NS5A binding-defective mutant of LASP-1. We further demonstrated that LASP-1 was involved in the replication stage of the HCV life cycle. Importantly, LASP-1 expression levels were increased in persistently infected cells with HCV. These data suggest that HCV modulates LASP-1 via NS5A in order to regulate virion levels and maintain a persistent infection.

Keywords

References

  1. Ardelt, P., Grunemay, N., Strehl, A., Jilg, C., Miernik, A., Kneitz, B., and Butt, E. (2013). LASP-1, a novel urinary marker for detection of bladder cancer. Urol. Oncol. 31, 1591-1598. https://doi.org/10.1016/j.urolonc.2012.02.002
  2. Bartenschlager, R., Lohmann, V., and Penin, F. (2013). The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection. Nat. Rev. Microbiol. 11, 482-496. https://doi.org/10.1038/nrmicro3046
  3. Chew, C.S., Chen, X., Parente, J.A. Jr., Tarrer, S., Okamoto, C., and Qin, H.Y. (2002). Lasp-1 binds to nonmuscle F-actin in vitro and is localized within multiple sites of dynamic actin assembly in vivo. J. Cell Sci. 115, 4787- 4799. https://doi.org/10.1242/jcs.00174
  4. Giannini, C. and Brechot, C. (2003). Hepatitis C virus biology. Cell Death Differ. 10 Suppl 1, S27-S38. https://doi.org/10.1038/sj.cdd.4401121
  5. Gitto, S., Gamal, N., and Andreone P. (2017). NS5A inhibitors for the treatment of hepatitis C infection. J. Viral Hepat. 24, 180-186. https://doi.org/10.1111/jvh.12657
  6. Gottwein, J.M., Pham, L.V., Mikkelsen, L.S., Ghanem, L., Ramirez, S., Scheel, T.K.H., Carlsen, T.H.R., and Bukh, J. (2018). Efficacy of NS5A inhibitors against hepatitis C virus genotypes 1-7 and escape variants. Gastroenterology 154, 1435-1448. https://doi.org/10.1053/j.gastro.2017.12.015
  7. Grunewald, T. and Butt, E. (2008). The LIM and SH3 domain protein family: structural proteins or signal transducers or both. Mol. Cancer 7, 31. https://doi.org/10.1186/1476-4598-7-31
  8. Grunewald, T.G., Kammerer, U., Kapp, M., Eck, M., Dietl, J., Butt, E., and Honig, A. (2007). Nuclear localization and cytosolic overexpression of LASP-1 correlates with tumor size and nodal-positivity of human breast carcinoma. BMC Cancer 7, 198. https://doi.org/10.1186/1471-2407-7-198
  9. Keicher, C., Gambaryan, S., Schulze, E., Marcus, K., Meyer, H.E., and Butt, E. (2004). Phosphorylation of mouse LASP-1 on threonine 156 by cAMPand cGMP-dependent protein kinase. Biochem. Biophys. Res. Commun. 324, 308-316. https://doi.org/10.1016/j.bbrc.2004.08.235
  10. Larson, S.M. and Davidson, A.R. (2000). The identification of conserved interactions within the SH3 domain by alignment of sequences and structures. Protein Sci. 9, 2170-2180. https://doi.org/10.1110/ps.9.11.2170
  11. Li, B., Zhuang, L., and Trueb, B. (2004). Zyxin interacts with the SH3 domains of the cytoskeletal proteins LIM-nebulette and Lasp-1. J. Biol. Chem. 279, 20401-20410. https://doi.org/10.1074/jbc.M310304200
  12. Lim, Y.S. and Hwang, S.B. (2011). Hepatitis C virus NS5A protein interacts with phosphatidylinositol 4-kinase type IIIalpha and regulates viral propagation. J. Biol. Chem. 286, 11290-11298. https://doi.org/10.1074/jbc.M110.194472
  13. Lim, Y.S., Tran, H.T., Park, S.J., Yim, S.A., and Hwang, S.B. (2011). Peptidylprolyl isomerase Pin1 is a cellular factor required for hepatitis C virus propagation. J. Virol. 85, 8777-8788. https://doi.org/10.1128/JVI.02533-10
  14. Lindenbach, B.D. and Rice, C.M. (2005). Unravelling hepatitis C virus replication from genome to function. Nature 436, 933-938. https://doi.org/10.1038/nature04077
  15. Luong, T.T.D., Tran, G.V.Q., Shin, D.J., Lim, Y.S., and Hwang, S.B. (2017). Hepatitis C virus exploits Death receptor 6-mediated signaling pathway to facilitate viral propagation. Sci. Rep. 7, 6445. https://doi.org/10.1038/s41598-017-06740-9
  16. Mihlan, S., Reiss, C., Thalheimer, P., Herterich, S., Gaetzner, S., Kremerskothen, J., Pavenstadt, H.J., Lewandrowski, U., Sickmann, A., and Butt, E. (2013). Nuclear import of LASP-1 is regulated by phosphorylation and dynamic protein-protein interactions. Oncogene 32, 2107-2113. https://doi.org/10.1038/onc.2012.216
  17. Nguyen, T.T.T., Park, E.M., Lim, Y.S., and Hwang, S.B. (2018). Nonstructural protein 5A impairs DNA damage repair: implications for hepatitis C virusmediated hepatocarcinogenesis. J. Virol. 92, e00178-18.
  18. Park, C., Min, S., Park, E.M., Lim, Y.S., Kang, S., Suzuki, T., Shin, E.C., and Hwang, S.B. (2015). Pim kinase interacts with nonstructural 5A protein and regulates hepatitis C virus entry. J. Virol. 89, 10073-10086. https://doi.org/10.1128/JVI.01707-15
  19. Pawlotsky, J.M., Flisiak, R., Sarin, S.K., Rasenack, J., Piratvisuth, T., Chuang, W.L., Peng, C.Y., Foster, G.R., Shah, S., Wedemeyer, H., et al. (2015). Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection. Hepatology 62, 1013-1023. https://doi.org/10.1002/hep.27960
  20. Pham, H.T., Nguyen, T.T.T., Nguyen, L.P., Han, S.S., Lim, Y.S., and Hwang, S.B. (2019). Hepatitis C virus downregulates ubiquitin-conjugating enzyme E2S expression to prevent proteasomal degradation of NS5A, leading to host cells more sensitive to DNA damage. J. Virol. 93, e01240-18.
  21. Saksela, K., Cheng, G., and Baltimore, D. (1995). Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for downregulation of CD4. EMBO J. 14, 484-491. https://doi.org/10.1002/j.1460-2075.1995.tb07024.x
  22. Tan, S.L., Nakao, H., He, Y., Vijaysri, S., Neddermann, P., Jacobs, B.L., Mayer, B.J., and Katze, M.G. (1999). NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling. Proc. Natl. Acad. Sci. U. S. A. 96, 5533-5538. https://doi.org/10.1073/pnas.96.10.5533
  23. Tang, R., Kong, F., Hu, L., You, H., Zhang, P., Du, W., and Zheng, K. (2012). Role of hepatitis B virus X protein in regulating LIM and SH3 protein 1 (LASP-1) expression to mediate proliferation and migration of hepatoma cells. Virol. J. 9, 163. https://doi.org/10.1186/1743-422X-9-163
  24. Tomasetto, C., Moog-Lutz, C., Régnier, C.H., Schreiber, V., Basset, P., and Rio, M.C. (1995a). Lasp-1 (MLN 50) defines a new LIM protein subfamily characterized by the association of LIM and SH3 domains. FEBS Lett. 373, 245-249. https://doi.org/10.1016/0014-5793(95)01040-L
  25. Tomasetto, C., Regnier, C., Moog-Lutz, C., Mattei, M.G., Chenard, M.P., Lidereau, R., Basset, P., and Rio, M.C. (1995b). Identification of four novel human genes amplified and overexpressed in breast carcinoma and localized to the q11-q21.3 region of chromosome 17. Genomics 28, 367-376. https://doi.org/10.1006/geno.1995.1163
  26. Wang, H., Li, W., Jin, X., Cui, S., and Zhao, L. (2013). LIM and SH3 protein 1, a promoter of cell proliferation and migration, is a novel independent prognostic indicator in hepatocellular carcinoma. Eur. J. Cancer 49, 974-983. https://doi.org/10.1016/j.ejca.2012.09.032
  27. Winters, M.J. and Pryciak, P.M. (2005). Interaction with the SH3 domain protein Bem1 regulates signaling by the Saccharomyces cerevisiae p21-activated kinase Ste20. Mol. Cell. Biol. 25, 2177-2190. https://doi.org/10.1128/MCB.25.6.2177-2190.2005
  28. You, H., Kong, F., Zhou, K., Wei, X., Hu, L., Hu, W., Luo, W., Kou, Y., Liu, X., Chen, X., et al. (2018). HBX protein promotes LASP-1 expression through activation of c-Jun in human hepatoma cells. J. Cell. Physiol. 233, 7279-7291. https://doi.org/10.1002/jcp.26560
  29. Zhao, L., Wang, H., Liu, C., Liu, Y., Wang, X., Wang, S., Sun, X., Li, J., Deng, Y., Jiang, Y., et al. (2010). Promotion of colorectal cancer growth and metastasis by the LIM and SH3 domain protein 1. Gut 59, 1226-1235. https://doi.org/10.1136/gut.2009.202739